Loading…
In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL‐1 and IL‐18
CD4+ T lymphocytes are required to induce spontaneous autoimmune diabetes in the NOD mouse. Since pancreatic β cells upregulate Fas expression upon exposure to pro‐inflammatory cytokines, we studied whether the diabetogenic action of CD4+ T lymphocytes depends on Fas expression on target cells. We a...
Saved in:
Published in: | European journal of immunology 2011-05, Vol.41 (5), p.1344-1351 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | CD4+ T lymphocytes are required to induce spontaneous autoimmune diabetes in the NOD mouse. Since pancreatic β cells upregulate Fas expression upon exposure to pro‐inflammatory cytokines, we studied whether the diabetogenic action of CD4+ T lymphocytes depends on Fas expression on target cells. We assayed the diabetogenic capacity of NOD spleen CD4+ T lymphocytes when adoptively transferred into a NOD mouse model combining: (i) Fas‐deficiency, (ii) FasL‐deficiency, and (iii) SCID mutation. We found that CD4+ T lymphocytes require Fas expression in the recipients' target cells to induce diabetes. IL‐1β has been described as a key cytokine involved in Fas upregulation on mouse β cells. We addressed whether CD4+ T cells require IL‐1β to induce diabetes. We also studied spontaneous diabetes onset in NOD/IL‐1 converting enzyme‐deficient mice, in NOD/IL‐1β‐deficient mice, and CD4+ T‐cell adoptively transferred diabetes into NOD/SCID IL‐1β‐deficient mice. Neither IL‐1β nor IL‐18 are required for either spontaneous or CD4+ T‐cell adoptively transferred diabetes. We conclude that CD4+ T‐cell‐mediated β‐cell damage in autoimmune diabetes depends on Fas expression, but not on IL‐1β unveiling the existing redundancy regarding the cytokines involved in Fas upregulation on NOD β cells in vivo. |
---|---|
ISSN: | 0014-2980 1521-4141 |
DOI: | 10.1002/eji.201041216 |